Last reviewed · How we verify
Silicone Oil — Competitive Intelligence Brief
marketed
Intraocular tamponade agent
Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
Silicone Oil (Silicone Oil) — National Eye Institute (NEI). Silicone oil acts as a temporary intraocular tamponade agent that fills the vitreous cavity to support retinal reattachment and maintain eye shape during healing.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Silicone Oil TARGET | Silicone Oil | National Eye Institute (NEI) | marketed | Intraocular tamponade agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Intraocular tamponade agent class)
- National Eye Institute (NEI) · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Silicone Oil CI watch — RSS
- Silicone Oil CI watch — Atom
- Silicone Oil CI watch — JSON
- Silicone Oil alone — RSS
- Whole Intraocular tamponade agent class — RSS
Cite this brief
Drug Landscape (2026). Silicone Oil — Competitive Intelligence Brief. https://druglandscape.com/ci/silicone-oil. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing